protein

SARS-COV-2 S trimer Protein (XBB.1.16, HEK293, His)

HY-P702821

2 μg;5 μg;10 μg;50 μg;100 μg

35;65;108;280;450 USD

SARS-COV-2 S trimer Protein (XBB.1.16, HEK293, His)

proteins

HEK293

2 μg;5 μg;10 μg;50 μg;100 μg

35;65;108;280;450 USD

The SARS-Cov-2 S glycoprotein is a SARS-Cov-2 S glycoprotein. The amino acid sequence 1261-1267a.a of the SARS-Cov-2 S glycoprotein is transmembrane. The SARS-Cov-2 S glycoprotein is a highly glycosylated trimer, each of which consists of 1260 amino acids (residues 14-1273), divided into four structural domains: the n-terminal domain (NTD), the c-terminal domain (CTD, also known as the receptor-binding domain, RBD), and two subdomains (SD1 and SD2). SARS-COV-2 S trimer Protein (XBB.1.16, HEK293, His) is the recombinant virus-derived SARS-COV-2 S trimer, expressed by HEK293 , with C-His labeled tag. ,

Virus

SARS-Cov-2 is a enveloped positive-sense single-stranded RNA virus that causes COVID-19. SARS-CoV-2 possesses four structural proteins, namely the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M), and nucleocapsid protein (N). The SARS-Cov-2 S glycoprotein is located on the exterior of the viral particle, giving the coronavirus its crown-like appearance. The SARS-Cov-2 S glycoprotein can mediate the attachment and entry of viral particles into host cells and is an important target for vaccine development, antibody therapy, and antigen-based diagnostic esting [1] [2] [3] [4] [5] .

S protein; Spike glycoprotein; S glycoprotein; COVID-19; XBB.1.16

Greater than 90% as determined by Tris-Bis PAGE.

Supplied as a 0.22 μm filtered solution in sodium citrate, 200 mM NaCl, 0.02% Tween-80,pH 6.0.

Shipping with dry ice